Market Cap (In HKD)
7.12 Billion
Revenue (In HKD)
4.51 Billion
Net Income (In HKD)
969.51 Million
Avg. Volume
693.43 Thousand
- Currency
- HKD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 6.61-10.76
- PE
- -
- EPS
- -
- Beta Value
- 0.81
- ISIN
- KYG2110P1000
- CUSIP
- G2110P100
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Zhenjiang Li
- Employee Count
- -
- Website
- https://www.shineway.com
- Ipo Date
- 2004-12-02
- Details
- China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers modern Chinese medicines in the form of soft capsules, granules, and injections, as well as TCM Formula Granules in various therapeutic areas, including cardio-cerebrovascular, anti-viral, orthopedics, pediatrics, gynecology, and gastroenterology. It also trades in agricultural products. The company was incorporated in 2004 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited is a subsidiary of Forway Investment Limited.
More Stocks
-
AAVMYABN AMRO Bank N.V.
AAVMY
-
0IJNExelon Corporation
0IJN
-
TU
-
BAI
-
BB
-
WTBWhitbread plc
WTB
-
IDEXIdeanomics, Inc.
IDEX
-
2708Kuze Co., Ltd.
2708